.
MergerLinks Header Logo

New Deal


Announced

Completed

Sofina and Temasek led the $80m Series C round in Oviva.

Financials

Edit Data
Transaction Value£59m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private Equity

Minority

Completed

Acquisition

Single Bidder

digital health

Venture Capital

Friendly

United Kingdom

Medical Services

Private

Cross Border

Synopsis

Edit

Investment firms Sofina and Temasek led the $80m Series C round in Oviva, a digital health startup which provides diet and lifestyle coaching. Existing investors that participated included AlbionVC, Earlybird, Eight Roads Ventures, F-Prime Capital, MTIP, and several angel investors. Sofina and Temasek each acquired a minority stake of 10%. "We see great potential in Oviva. Its solution is an example of how major healthcare and societal issues like diabetes can be addressed by the application of digital solutions, which is a topic our healthcare sector team has a strong conviction for. Oviva has already made big steps in the right direction in recent years and we believe that this was just the beginning," Harold Boël, Sofina CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US